BRIEF-Aveo Pharmaceuticals announced discontinuation of focal study
September 12, 2016 at 06:22 AM EDT
* Announced discontinuation of focal study, a phase 2, placebo controlled clinical study, evaluating ficlatuzumab
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.